BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18595240)

  • 1. The significance of TPSA, free to total PSA ratio and PSA density in prostate carcinoma diagnostics.
    Milkovic B; Hadzi-Djokic J; Dzamic Z; Pejcic T
    Acta Chir Iugosl; 2007; 54(4):105-7. PubMed ID: 18595240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL.
    Stephan C; Stroebel G; Heinau M; Lenz A; Roemer A; Lein M; Schnorr D; Loening SA; Jung K
    Cancer; 2005 Sep; 104(5):993-1003. PubMed ID: 16007682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of free/total PSA ratio and PSA density in distinguishing benign prostatic hypertrophy from prostatic cancer].
    Mosquera Madera J; Pinto Sierra I; Enguix Armada A; Sahagún Argüello JL
    Actas Urol Esp; 2001 Oct; 25(9):651-5. PubMed ID: 11765549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited usefulness of the free-to-total prostate-specific antigen ratio for the diagnosis and staging of prostate cancer in Japanese men.
    Sakai I; Harada K; Hara I; Eto H; Miyake H
    Int J Clin Oncol; 2004 Feb; 9(1):64-7. PubMed ID: 15162829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.
    Djavan B; Remzi M; Zlotta AR; Ravery V; Hammerer P; Reissigl A; Dobronski P; Kaisary A; Marberger M
    Urology; 2002 Oct; 60(4 Suppl 1):4-9. PubMed ID: 12384156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: impact of changing disease demographics.
    Miller MC; O'Dowd GJ; Partin AW; Veltri RW
    Urology; 2001 Jun; 57(6):1105-11. PubMed ID: 11377319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together.
    Serdar MA; Oguz O; Olgun A; Seçkin B; Ilgan S; Hasimi A; Salih M; Peker F; Kutluay T
    Ann Clin Lab Sci; 2002; 32(1):22-30. PubMed ID: 11848613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer.
    Zou BZ; Wen H; Luo HJ; Luo WC; Xie QT; Zhou MT
    Ir J Med Sci; 2023 Dec; 192(6):2681-2687. PubMed ID: 37414978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical utility of measuring free-to-total prostate-specific antigen (PSA) ratio and PSA density in differentiating between benign prostatic hyperplasia and prostate cancer.
    Kochañska-Dziurowicz AA; Mielniczuk MR; Stojko A; Kaletka J
    Br J Urol; 1998 Jun; 81(6):834-8. PubMed ID: 9666767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1-10.0 ng/mL.
    Okegawa T; Kinjo M; Watanabe K; Noda H; Kato M; Miyata A; Murata A; Yoshii M; Nutahara K; Higashihara E
    BJU Int; 2000 Apr; 85(6):708-14. PubMed ID: 10759671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance and limitations of f/tPSA in differential diagnosis of prostate cancer with tPSA levels between 4 and 10 ng/ml].
    Chen ZD; Wei SM; Cai SL
    Zhonghua Wai Ke Za Zhi; 2004 May; 42(10):593-5. PubMed ID: 15265401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of percent free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients.
    Minardi D; Galosi AB; Recchioni A; Giammarco L; Polito M; Muzzonigro G
    Urol Int; 2001; 67(4):272-82. PubMed ID: 11741128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of the free to total prostate specific antigen ratio and prostate specific antigen density for detecting prostate cancer in Japanese patients.
    Maeda H; Arai Y; Okubo K; Aoki Y; Okada T; Maekawa S
    Int J Urol; 1998 Jul; 5(4):343-8. PubMed ID: 9712442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of age on prostate cancer screening index.
    Shan J; Liu Z; Geng X; Feng Y; Yang X; Xu H; Zhou X; Ma W; Zhu H; Shi H
    J Clin Lab Anal; 2022 Jan; 36(1):e24098. PubMed ID: 34816496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of total prostate specific antigen and free to total prostate specific antigen ratio in the diagnosis of prostate cancer.
    Chakraborty L; Ahmed AN; Paul BK; Haque A; Ara A; Nabi S; Nessa M
    Mymensingh Med J; 2012 Jan; 21(1):98-102. PubMed ID: 22314462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant Diagnostic Value of Free-Serum PSA (FPSA)/Prostate-Specific Antigen Density (PSAD) and (F/T)/PSAD for Prostate Cancer of the Chinese Population in a Single Institution.
    Nan LB; Yin XT; Gao JP
    Med Sci Monit; 2019 Nov; 25():8345-8351. PubMed ID: 31691648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free/total PSA ratio improves differentiation of benign and malignant disease of the prostate: critical analysis of two different test populations.
    Veltri RW; Miller MC
    Urology; 1999 Apr; 53(4):736-45. PubMed ID: 10197849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer detection by prostate-specific antigen-related parameters.
    Segawa N; Gohji K; Iwamoto Y; Ueda H; Katsuoka Y
    Hinyokika Kiyo; 2003 Jul; 49(7):405-10. PubMed ID: 12968483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of free-to-total prostate specific antigen (F/T PSA), prostate specific antigen density (PSAD) and (F/T)/PSAD sensitivity on reduction of unnecessary prostate biopsies for patients with PSA in gray zone.
    Milkovic B; Dzamic Z; Pejcic T; Kajmakovic B; Nikolic D; Cirovic D; Knezevic T; Dzamic D; Hadzi-Djokic J
    Ann Ital Chir; 2014; 85(5):448-53. PubMed ID: 25599711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PSA density as a better predictor of prostate cancer than percent-free PSA in a repeat biopsy.
    Chen CS; Wang SS; Li JR; Cheng CL; Yang CR; Chen WM; Ou YC; Ho HC; Chiu KY; Yang CK
    J Chin Med Assoc; 2011 Dec; 74(12):552-5. PubMed ID: 22196470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.